Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor: Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (αIR-3)

Hisanori Kato, Teresa N. Faria, Bethel Stannard, Charles Roberts, Derek LeRoith

Research output: Contribution to journalArticle

236 Citations (Scopus)

Abstract

The insulin-like growth factor-I (IGF-I) receptor is a member of a large family of transmembrane signal transducing molecules. The defining characteristic of this class of receptors is the intrinsic tyrosine kinase activity of the cytoplasmic domain. While it has been demonstrated that this tyrosine kinase activity is necessary for the action of a number of transmembrane tyrosine kinase receptors, no evidence of this type has been adduced to date with respect to the signaling requirement of the IGF-I receptor. We have now shown that stably transfected NIH-3T3 cell lines overexpressing human IGF-I receptors display increased responses to IGF-I and an IGF-I-mimetic antibody, αIR-3, in terms of short, intermediate, and long term actions initiated by activation of the IGF-I receptor. These include receptor autophosphorylation, activation of phosphatidylinositol-3-kinase and 2-deoxyglucose up-take, induction of ornithine decarboxylase gene expression, and stimulation of thymidine incorporation. In short term responses, the kinetics seen with αIR-3 were slower than those seen with IGF-I. These effects were severely decreased in clones expressing human IGF-I receptors in which the lysine residue in the ATP-binding site of the tyrosine kinase domain had been mutated to alanine or arginine. This was true for both IGF-I and αIR-3. These results indicate that, for all parameters tested, the tyrosine kinase activity of the IGF-I receptor is necessary for activation of the IGF-I-stimulated signal transduction cascade. Additionally, the effects of αIR-3 also require tyrosine kinase activity.

Original languageEnglish (US)
Pages (from-to)2655-2661
Number of pages7
JournalJournal of Biological Chemistry
Volume268
Issue number4
StatePublished - Feb 5 1993
Externally publishedYes

Fingerprint

Signal transduction
IGF Type 1 Receptor
Insulin-Like Growth Factor I
Protein-Tyrosine Kinases
Signal Transduction
Phosphotransferases
Antibodies
Chemical activation
Phosphatidylinositol 3-Kinase
NIH 3T3 Cells
Ornithine Decarboxylase
Deoxyglucose
Receptor Protein-Tyrosine Kinases
Gene expression
Alanine
Thymidine
Lysine
Arginine
Clone Cells
Adenosine Triphosphate

ASJC Scopus subject areas

  • Biochemistry

Cite this

@article{d75b0e275e984d3f9617b01d3cd3a02f,
title = "Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor: Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (αIR-3)",
abstract = "The insulin-like growth factor-I (IGF-I) receptor is a member of a large family of transmembrane signal transducing molecules. The defining characteristic of this class of receptors is the intrinsic tyrosine kinase activity of the cytoplasmic domain. While it has been demonstrated that this tyrosine kinase activity is necessary for the action of a number of transmembrane tyrosine kinase receptors, no evidence of this type has been adduced to date with respect to the signaling requirement of the IGF-I receptor. We have now shown that stably transfected NIH-3T3 cell lines overexpressing human IGF-I receptors display increased responses to IGF-I and an IGF-I-mimetic antibody, αIR-3, in terms of short, intermediate, and long term actions initiated by activation of the IGF-I receptor. These include receptor autophosphorylation, activation of phosphatidylinositol-3-kinase and 2-deoxyglucose up-take, induction of ornithine decarboxylase gene expression, and stimulation of thymidine incorporation. In short term responses, the kinetics seen with αIR-3 were slower than those seen with IGF-I. These effects were severely decreased in clones expressing human IGF-I receptors in which the lysine residue in the ATP-binding site of the tyrosine kinase domain had been mutated to alanine or arginine. This was true for both IGF-I and αIR-3. These results indicate that, for all parameters tested, the tyrosine kinase activity of the IGF-I receptor is necessary for activation of the IGF-I-stimulated signal transduction cascade. Additionally, the effects of αIR-3 also require tyrosine kinase activity.",
author = "Hisanori Kato and Faria, {Teresa N.} and Bethel Stannard and Charles Roberts and Derek LeRoith",
year = "1993",
month = "2",
day = "5",
language = "English (US)",
volume = "268",
pages = "2655--2661",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "4",

}

TY - JOUR

T1 - Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor

T2 - Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (αIR-3)

AU - Kato, Hisanori

AU - Faria, Teresa N.

AU - Stannard, Bethel

AU - Roberts, Charles

AU - LeRoith, Derek

PY - 1993/2/5

Y1 - 1993/2/5

N2 - The insulin-like growth factor-I (IGF-I) receptor is a member of a large family of transmembrane signal transducing molecules. The defining characteristic of this class of receptors is the intrinsic tyrosine kinase activity of the cytoplasmic domain. While it has been demonstrated that this tyrosine kinase activity is necessary for the action of a number of transmembrane tyrosine kinase receptors, no evidence of this type has been adduced to date with respect to the signaling requirement of the IGF-I receptor. We have now shown that stably transfected NIH-3T3 cell lines overexpressing human IGF-I receptors display increased responses to IGF-I and an IGF-I-mimetic antibody, αIR-3, in terms of short, intermediate, and long term actions initiated by activation of the IGF-I receptor. These include receptor autophosphorylation, activation of phosphatidylinositol-3-kinase and 2-deoxyglucose up-take, induction of ornithine decarboxylase gene expression, and stimulation of thymidine incorporation. In short term responses, the kinetics seen with αIR-3 were slower than those seen with IGF-I. These effects were severely decreased in clones expressing human IGF-I receptors in which the lysine residue in the ATP-binding site of the tyrosine kinase domain had been mutated to alanine or arginine. This was true for both IGF-I and αIR-3. These results indicate that, for all parameters tested, the tyrosine kinase activity of the IGF-I receptor is necessary for activation of the IGF-I-stimulated signal transduction cascade. Additionally, the effects of αIR-3 also require tyrosine kinase activity.

AB - The insulin-like growth factor-I (IGF-I) receptor is a member of a large family of transmembrane signal transducing molecules. The defining characteristic of this class of receptors is the intrinsic tyrosine kinase activity of the cytoplasmic domain. While it has been demonstrated that this tyrosine kinase activity is necessary for the action of a number of transmembrane tyrosine kinase receptors, no evidence of this type has been adduced to date with respect to the signaling requirement of the IGF-I receptor. We have now shown that stably transfected NIH-3T3 cell lines overexpressing human IGF-I receptors display increased responses to IGF-I and an IGF-I-mimetic antibody, αIR-3, in terms of short, intermediate, and long term actions initiated by activation of the IGF-I receptor. These include receptor autophosphorylation, activation of phosphatidylinositol-3-kinase and 2-deoxyglucose up-take, induction of ornithine decarboxylase gene expression, and stimulation of thymidine incorporation. In short term responses, the kinetics seen with αIR-3 were slower than those seen with IGF-I. These effects were severely decreased in clones expressing human IGF-I receptors in which the lysine residue in the ATP-binding site of the tyrosine kinase domain had been mutated to alanine or arginine. This was true for both IGF-I and αIR-3. These results indicate that, for all parameters tested, the tyrosine kinase activity of the IGF-I receptor is necessary for activation of the IGF-I-stimulated signal transduction cascade. Additionally, the effects of αIR-3 also require tyrosine kinase activity.

UR - http://www.scopus.com/inward/record.url?scp=0027402935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027402935&partnerID=8YFLogxK

M3 - Article

C2 - 7679099

AN - SCOPUS:0027402935

VL - 268

SP - 2655

EP - 2661

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 4

ER -